Elixir Medical Clinical Evaluation of the DESolve® Novolimus Eluting Bioresorbable Coronary Scaffold System - The DESolve Nx Trial
Clinical trial NCT02086045 · COMPLETED
Trial details
- NCT number
- NCT02086045
- Sponsor
- Elixir Medical Corporation
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2011-11-01
- Primary completion
- 2013-06-01
- Enrollment
- 126
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.